ArticlePloS one2020

Optimal PD-L1-high cutoff for association with overall survival in patients with urothelial cancer treated with durvalumab monotherapy.

Magdalena Zajac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.